Pharmaceuticals

Infasurf Market 2026–2035 expanding neonatal respiratory care

March 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Infasurf Market Over The Period 2026–2030?

The historical growth was influenced by a substantial prevalence of neonatal respiratory distress syndrome, the established effectiveness of surfactant replacement, the enlargement of NICU facilities, enhanced survival rates for premature infants, and the implementation of surfactant therapy across hospitals.

The anticipated expansion over the forecast period stems from factors such as an increase in global preterm births, greater expenditure on neonatal healthcare, enhanced availability of NICU care, progress in surfactant formulation, and the expansion of neonatal care infrastructure.

Prominent trends during the forecast period involve a heightened adoption of natural lung surfactants, an increase in preterm birth rates, refined neonatal intensive care protocols, prompt intervention for respiratory distress, and the standardization of neonatal surfactant therapy.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20100&type=smp

Which Economic Or Industry Drivers Are Impacting The Infasurf Market?

The increasing incidence of premature births is anticipated to fuel the expansion of the infasurf market in the foreseeable future. A premature birth, or preterm birth, is characterized by a baby being born before 37 weeks of gestation, as opposed to a full-term delivery which typically occurs around 40 weeks, and such early births can lead to numerous health issues for the infant, including respiratory problems, developmental delays, and an elevated likelihood of long-term disabilities. Several elements contribute to the growing frequency of premature births, such as increased maternal age, higher instances of multiple pregnancies due to fertility treatments, and the influence of chronic health conditions and infections during pregnancy. Infasurf (calfactant) is delivered directly into the lungs of premature infants to either prevent or manage respiratory distress syndrome (RDS) by decreasing surface tension and enhancing lung functionality. For example, in October 2024, a report from the University of Bristol, a public research university based in the UK, indicated that approximately one in 13 births is preterm, amounting to over 50,000 cases annually. Despite preventative efforts for women at high risk, preterm birth rates continue to climb. Consequently, the rising occurrence of premature births is fostering the growth of the infasurf market. The expansion of the infasurf market is anticipated to be driven by increasing healthcare spending in the future. Healthcare spending encompasses all financial resources directed by individuals, governments, private insurers, and other entities toward providing healthcare services and products. This increase in healthcare expenditure stems from an aging global populace, continuous innovations in medical technology, a growing incidence of chronic illnesses, and a heightened need for healthcare provisions. Infasurf offers advantages for healthcare spending by lessening the financial burden associated with prolonged hospitalizations and intricate respiratory treatments for premature infants suffering from respiratory distress syndrome, thereby enhancing cost-effectiveness in neonatal care. For example, in May 2024, data from the Office for National Statistics, a UK government department, showed that between 2022 and 2023, healthcare spending in the UK rose by 5.6%, a significant increase compared to the 0.9% growth observed in 2022. In 2023, the UK’s healthcare expenditure reached approximately $317.63 billion (£292 billion). Consequently, the upward trend in healthcare expenditure is stimulating the growth of the infasurf market.

How Is The Infasurf Market Divided Into Its Major Segments?

The infasurf market covered in this report is segmented –

1) By Patient Demographics: Premature Infants, Full-Term Infants, Age Groups

2) By Distribution Channel: Hospitals, Specialty Clinics, Online Pharmacies, Pharmacies

3) By Application: Neonatal Respiratory Distress Syndrome, Other Respiratory Conditions

Who Are The Prominent Organizations Shaping The Infasurf Market?

Major companies operating in the infasurf market are ONY Biotech Inc.

Read the full infasurf market report here:

https://www.thebusinessresearchcompany.com/report/infasurf-global-market-report

What Are The Top-Performing Regions Within The Infasurf Market?

North America was the largest region in the infasurf market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the infasurf market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Infasurf Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20100&type=smp

Browse Through More Reports Similar to the Global Infasurf Market 2026, By The Business Research Company

Financial Analytics Market Report 2026

https://www.thebusinessresearchcompany.com/report/financial-analytics-global-market-report

Data Lake Market Report 2026

https://www.thebusinessresearchcompany.com/report/data-lake-global-market-report

Trade Finance Market Report 2026

https://www.thebusinessresearchcompany.com/report/trade-finance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795